Bowel Urgency in Inflammatory Bowel Disease (URGENT-1)

March 22, 2024 updated by: Paris IBD Center

Bowel urgency is commonly defined as the sudden need to rush to the bathroom to empty one's bowel. In the field of inflammatory bowel disease (IBD) (including Crohn's disease (CD) and ulcerative colitis (UC)), bowel urgency is part of the top five research priorities for future IBD nursing research, and it is a symptom that patients consider to be most important when prioritizing their disease control. Urgency is a patient-reported outcome associated with compromised quality of life and future risk of hospitalizations, corticosteroids, and colectomy in patients with UC.

A meta-analysis of 321 studies examining bowel urgency revealed that only one-third of these clinical studies clearly defined the concept of bowel urgency. Definition of bowel urgency was heterogeneous as 14 different definitions were identified. In most of these studies, non-validated questionnaires were used. They are based on subjective responses of the patients, and they could determine evaluation bias. These data emphasize the lack of standardization in bowel urgency assessment.

Study Overview

Study Type

Observational

Enrollment (Actual)

1000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Neuilly-sur-Seine, France, 92200
        • Institut des MICI

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Inflammatory bowel disease patients

Description

Inclusion Criteria:

  • Male or female, aged at least 18 years old
  • Diagnosis of inflammatory bowel disease according to the European Crohn´s and Colitis Organisation criteria for at least 3 months
  • Person who has received full information about the organization of the research and who has not objected to his or her participation and to the use of his or her data
  • Person affiliated to or beneficiary of a social security plan

Exclusion Criteria:

  • Person unable to comply with study procedures

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prevalence of bowel urgency in a cohort of patients with inflammatory bowel disease
Time Frame: Through study completion, an average of 12 months
Inability to defer defecation for more than 15 minutes in patients with inflammatory bowel disease
Through study completion, an average of 12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
To identify IBD-related risk factors associated with an increased risk of bowel urgency
Time Frame: Through study completion, an average of 12 months
Inability to defer defecation for more than 15 minutes and potentially predictive factors (i.e. baseline characteristics)
Through study completion, an average of 12 months
Prevalence of bowel urgency in a cohort of Crohn's disease patients
Time Frame: Through study completion, an average of 12 months
Inability to defer defecation for more than 15 minutes in patients with Crohn's disease
Through study completion, an average of 12 months
Prevalence of bowel urgency in a cohort of ulcerative colitis patients
Time Frame: Through study completion, an average of 12 months
Inability to defer defecation for more than 15 minutes in patients with ulcerative colitis
Through study completion, an average of 12 months
Development of the URGENT index (i.e. inflammatory bowel disease-specific bowel urgency index)
Time Frame: Through study completion, an average of 12 months
Components of the index based on variables describing in systematic review Caron B et al. Clin Gastroenterol Hepatol. 2023 and IBD expert opinion
Through study completion, an average of 12 months
Correlation between the URGENT index and the Urgency Numeric Rating Scale
Time Frame: Through study completion, an average of 12 months
Relationships between changes in the URGENT index and changes in the Urgency Numeric Rating Scale
Through study completion, an average of 12 months
Correlation between the URGENT index and a Global Visual Evaluation
Time Frame: Through study completion, an average of 12 months
Relationship between changes in the URGENT index and changes in the Global Visual Evaluation on a 10-point visual analog scale ranging from 0 (minimal activity) to 10 (maximal activity)
Through study completion, an average of 12 months
Most appropriate definition of bowel urgency for patients with IBD
Time Frame: Through study completion, an average of 12 months
Urgent desire to defecate and/or extreme desire to defecate and/or immediate need to defecate and/or inability to defer defecation for more than 2 minutes and/or inability to defer defecation for more than 5 minutes and/or inability to defer defecation for more than 20 minutes and/or inability to defer defecation for more than 30 minutes and/or having to rush to the toilet and/or not making it to a toilet in time and/or having to stop whatever to have a bowel movement and/or difficult to withstand urge to open bowels and/or running to the bathroom and/or inability to delay bowel movements
Through study completion, an average of 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 12, 2023

Primary Completion (Actual)

March 22, 2024

Study Completion (Actual)

March 22, 2024

Study Registration Dates

First Submitted

October 1, 2023

First Submitted That Met QC Criteria

October 1, 2023

First Posted (Actual)

October 5, 2023

Study Record Updates

Last Update Posted (Actual)

March 26, 2024

Last Update Submitted That Met QC Criteria

March 22, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Inflammatory Bowel Diseases

Clinical Trials on Collection of data related to bowel urgency

Subscribe